Health Trials

Recurrent Atypical/malignant Meningioma

1

Review clinical trials related to Recurrent Atypical/malignant Meningioma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults

Apatinib mesylate may be an effective treatment for recurrent atypical/malignant meningioma. This prospective clinical study is now planned to verify the effectiveness and safety of apatinib mesylate in the treatment of relapsed atypical/malignant meningioma.

Participants needed: 29
Trial details
Age: 18-70Biological sex: AllType: InterventionalSponsor: Beijing Sanbo Brain HospitalUpdated: Oct 15, 2024Locations: 1
Eligibility criteria

Age ≥18 years old (at the time of enrollment), regardless of gender. [+14]

Past application of anti-tumor angiogenesis drugs; [+14]

Read more